 
        Intra-articular analgesia in reducing postoperative pain post sacroiliac joint fusion
 
                                                    Intra-articular analgesia in reducing postoperative pain post sacroiliac joint fusion
Effectiveness of intra-articular analgesia in reducing postoperative pain after minimally invasive sacroiliac joint fusion: a double-blind randomized controlled trial.
Sci Rep. 2024 01-Sep;():. 10.1038/s41598-024-73638-8Synopsis
Forty-two patients undergoing minimally invasive sacroiliac joint fusion (MISJF) were randomized to receive intra-articular infiltration with bupivacaine 0.50% (n=22) or placebo (NaCl 0.9%) (n=19). The primary outcome was postoperative pain scores assessed using the visual analog scale (VAS) over 48 hours. Secondary outcomes included opioid consumption, patient satisfaction, recovery scores, adver...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.